VistaGen Therapeutics (NASDAQ: VTGN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of VistaGen Therapeutics (NASDAQ: VTGN) through any online brokerage.
The latest price target for VistaGen Therapeutics (NASDAQ: VTGN) was reported by Baird on Thursday, May 20, 2021. The analyst firm set a price target for 9.00 expecting VTGN to rise to within 12 months (a possible 913.40% upside). 0 analyst firms have reported ratings in the last year.
The stock price for VistaGen Therapeutics (NASDAQ: VTGN) is $0.8881 last updated Today at July 5, 2022, 4:36 PM UTC.
There are no upcoming dividends for VistaGen Therapeutics.
VistaGen Therapeutics’s Q1 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for VistaGen Therapeutics.
VistaGen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.